I-ARA-290

I-ARA-290 iyi-peptide yokwenziwa eyakhiwe 11 ama-amino acid, kususelwa kumodeli yesakhiwo enezinhlangothi ezintathu ye-endogenous hormone erythropoietin (I-EPO).

 

 

I-SKU: 198804 Isigaba:
Yabelana ngothando lwakho

I-ARA-290 iyi-peptide yokwenziwa eyakhiwe 11 ama-amino acid, ethathwe kumodeli yesakhiwo enezinhlangothi ezintathu zehomoni engapheli i-erythropoietin (I-EPO). Ilingisa isixhumi esibonakalayo esibophezelayo se-β-co-receptor ye-erythropoietin (βcR), ngokukhetha kusebenze iphrotheni ye-receptor yokulungisa. Okubaluleke nakakhulu, le nqubo igwema izingozi ezikhulayo ezingase zihlotshaniswe nama-receptors endabuko e-EPO.

Kuqale kwabikwa ngo 2008, ukuvela kwe-ARA-290 kusho uguquko lwamasu ocwaningweni lwe-EPO lusuka ekwelashweni kwe-hematopoietic luye ekulungiseni okuhlosiwe kwezicubu kanye i-immunomodulation.
Ngomshini, ngokubophezela ngokuhambisana okuphezulu ku-IRR, I-ARA-290 ngokukhetha ivula izindlela zokusayina eziwukhiye ezansi nomfula, kuhlanganise I-JAK2-STAT3 futhi I-PI3K-Act, okuyinto ekugcineni modulators ezibucayi like I-NF-kB.

Ngale kwalokhu, I-ARA-290 ibonisa imiphumela enamandla yokulwa nokuvuvukala kanye ne-immunomodulatory, ikhuthaza ukulungiswa kwe-neural futhi inciphise ubuhlungu be-neuropathic, ilawula imetabolism, futhi ikhombisa amandla okwelapha okwelapha i-fiber neuropathy encane, Isifo sikaCharcot-Marie-Tooth, kanye ne-diabetesic neuropathy.

Ukulandelana

H-Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH

Inombolo ye-CAS

1208243-50-8

I-Molecular Formula

I-C51H84N16O21

Isisindo samangqamuzana

1257.3

Ucwaningo lwe-ARA-290

1.Ukuthuthukisa Amandla e-Angiogenic kanye Namakhono Okuhlala we Amaseli E-Endothelial Progenitor Ejikelezayo:

  • Okokuqala, Izifo ze-ischemic zibonisa ukuphazamiseka okulimazayo kwe-vascular. Ngokudlanga kokukhuluphala kanye nesifo sikashukela, isibalo seziguli ezithintekile siyaqhubeka nokukhuphuka. Ngenxa yalokho, kubantu abanesifo esibi se-vascular, ukunqunywa kwesitho kusasele kuyinketho yokwelapha eyinhloko.
  • Ocwaningweni olufanele, I-ARA-290 inikezwe amagundane nge i-ischemia yesitho esingamahlalakhona (I-CLI). Imiphumela yabonisa ukuthi i-ARA-290 ithuthukisa kakhulu ukwanda/ukufuduka futhi imelane ne-apoptosis eyenziwe nge-hydrogen peroxide..
  • Ukwengeza, umjovo owodwa we-ARA-290 uthuthukise ukugeleza kwegazi kwezitho kanye nokuminyana kwe-capillary.
    Ngokuhlangene, Lokhu okutholakele kubonisa ukuthi ukusebenzisa i-ARA-290 njenge-adjuvant kungathuthukisa izakhiwo ze-angiogenic zangaphakathi. I-Endothelial colony forming cell(Ama-ECFCs) kanye ne-vivo yabo ukuya ezindaweni ze-ischemic, ngaleyo ndlela ivuselela i-angiogenesis. Ngakho, lokhu kunikeza indlela entsha yokwelapha esebenzayo yezifo ezingapheli ze-ischemic.

2.Ukwenza ngcono ukukhishwa kwe-insulini kanye nokubekezelela i-glucose ohlotsheni 2 Iziguli Zesifo Sikashukela:
Esizindeni se-metabolic, I-ARA-290 ithuthukisa kakhulu ukubekezelelwa kweglucose kumagundane anesifo sikashukela ngaphandle kokuthinta amagundane angenasifo sikashukela.. Ngokuqondile, ivuselela ukuphakama I-GSIS(Ukukhiqizwa kwe-insulin ekhiqizwa yi-glucose) amazinga, ekugcineni kuthuthukisa i-glucose oxidation futhi I-Adenosine triphosphate(I-ATP) ukukhiqiza. Ngalo mshini, ngokuthonya Isiteshi se-potassium esizwela i-ATP(IKATI) ukuvalwa kwesiteshi, ekugcineni kuba nomthelela ekukhiqizweni kwe-insulin.

3.I-Anti-inflammatory kanye Neuroprotective Effects:
Ukuhlola i-neuroinflammation, ocwaningweni lokwelapha olubandakanya amagundane ka Lewis nge ukuhlolwa kwe-autoimmune encephalomyelitis (I-EAE), ukuphathwa okuqhubekayo kwemijovo ye-ARA-290 kunciphisa kakhulu ukuqina kwe-EAE kumagundane. Ngokuqondene, lokhu kwelashwa kunciphisa ukuqoqwa kwamangqamuzana okuvuvukala emthonjeni womgogodla we-EAE futhi kwacindezela ukwanda nokuvezwa kwama-cytokines njenge-interleukin., I-tumor necrosis factor-α, kanye ne-inducible i-nitric oxide synthase ku-EAE rat umgogodla womgogodla.

Ngaphezu kwalokho, izifundo ze-in vitro zibonise ukuthi i-ARA-290 ivimbela Iseli le-Th1 ne-Th7 i-polarization kuma-EAE lymphocyte. Ndawonye, lokhu kuhlola kubonisa ukuthi i-ARA-290 inevelu yokwelapha engaba khona ye-multiple sclerosis.

4.Ukukhuthaza Ukulungiswa Kwemizwa Nokunciphisa Ubuhlungu Be-Neuropathic:
Ngokuphawulekayo, I-ARA-290 ingawela ngokuqondile umgoqo wegazi-ubuchopho, ukuyivumela ukuthi isebenze ngokuqondile i-ganglia yezimpande zomgogodla futhi i-microglia. Lapho, icindezela ukukhishwa okungavamile ohlelweni lwezinzwa olumaphakathi lobuchopho, kunciphisa ukuzwela okuphakathi, futhi ishintshe ngenkuthalo izici ze-neurotrophic ngenkathi kunciphisa ukuvuvukala ku-dorsal root ganglia ukulungisa isimiso sezinzwa esimaphakathi..

5.Ukuthuthukisa Ukulungiswa Kwezicubu Nokuvuselela Amandla:
Ekugcineni, I-ARA-290 isebenza kumaseli omzimba azalwa nawo aveza i-IRR, okukhuthaza ngamandla ukuhlukaniswa kwabo kusuka ku-phenotype ye-M1 e-pro-inflammatory kuya ku-phenotype elwa nokuvuvukala kanye ne-pro-repair M2. Ngenxa yalokho, icindezela izimpendulo ezivuvukalayo ngokwedlulele ngenkathi ivuselela ukugcinwa kwezici eziningi zokukhula, ukuhlanza amaseli e-apoptotic, kanye nokwakha imithambo yegazi emisha. Ekugcineni, lokhu kuthuthukisa ubuqotho besakhiwo kanye nezakhiwo zemishini yezicubu ezilungisiwe.

I-COA

I-HPLC

MS

(1) Izembe, G.; Garrigue, P.; Bennis, Y.; Stalin, J.; Inhliziyo, A.; I-Cerami, A.; Amabhodlela, M.; Blot-Chabaud, M.; Sabatier, F.; Dignat-George, F.; et al. I-ARA290, i-Specific Agonist ye-Erythropoietin/CD131 Heteroreceptor, Ithuthukisa I-Circulating Endothelial Progenitors’ Angiogenic Potential and Homing Amandla. Ukushaqeka 2016, 46 (4), 390-397. I-DOI: 10.1097/CS.0000000000000606.

(2) Muller, C.; Yassin, K.; Li, L.-S.; Iqabunga lesundu, M.; I-Efendic, S.; Igatsha lasentabeni, NGEMVA.; I-Cerami, A.; Amabhodlela, M.; Östenson, C.-G. I-ARA290 Ithuthukisa Ukukhishwa Kwe-insulini kanye Nokubekezelela I-Glucose Ohlotsheni 2 Amagundane e-Diabetic Goto-Kakizaki. Umuthi wamangqamuzana 2015, 21 (1), 969-978. I-DOI: 10.2119/molmed.2015.00267.

(3) U-Chen, H.; IsiLuo, B.; Yikuphi, X.; Xiong, J.; U-Liu, Z.; Jiang, M.; Shi, R.; Yan, C.; Wu, Y.; Zhang, Z. Imiphumela yokwelapha ye-nonerythropoietic erythropoietin analog ARA290 kurat lokuhlola le-autoimmune encephalomyelitis. Ijenali ye-Neuroimmunology 2014, 268 (1-2), 64-70. I-DOI: 10.1016/j.jneuroim.2014.01.006.

(4) ama-deVries, M. R.; de Jong, R. C. M.; Peters, H. A. B.; I-Haming, J. F.; Ama-Goumans, M. J.; I-Quax, P. H. A. I-Vegfr2 blockade ku-murine vein graft iphumela ekunciphiseni ukopha kwe-intraplaque kanye nezilonda eziqinile ze-atherosclerotic.. I-Atherossteosis 2014, 235 (2), e161-e162. I-DOI: 10.1016/j.isifo sokuqina kwemithambo yegazi.2014.05.463.

(5) I-Bastiaansen, T.; Carp, J.; I-Weasel, A.; de Boer, H.; imihlaba, S.; Aref, Z.; de Jong, R.; Peters, E.; ama-deVries, M.; van Oeren-Rietdijk, A.; et al. I-TLR4 Accessory Molecule RP105 (CD180) Ilawula i-Arteriogenesis ne-Angiogenesis. I-European Journal of Vascular and Endovascular Surgery 2014, 47 (6), 695-696. I-DOI: 10.1016/j.ejvs.2014.03.033.

(6) Ngayicosha, M.; Thiemermann, C.; I-Cerami, A.; Amabhodlela, M. Ukuphenyisisa iswishi yamangqamuzana ukuze kuvikelwe futhi kulungiswe izicubu: Imiphumela ehlala isikhathi eside ye-peptide encane engeyona i-erythropoietic eyenziwe nge-erythropoietin. I-Pharmacology & Imithi yokwelapha 2015, 151, 32-40. I-DOI: 10.1016/j.pharmthera.2015.02.005.

ukucaciswa

12mg

Ikhaya Sesha Whatsapp Amasevisi Umkhiqizo